BANK VONTOBEL/CALL/STRYKER CORP./380/0.1/20.09.24 Share Price

Warrant

DE000VM9PP76

Market Closed - Deutsche Boerse AG 11:35:52 14/06/2024 pm IST
0.32 EUR 0.00% Intraday chart for BANK VONTOBEL/CALL/STRYKER CORP./380/0.1/20.09.24
1 month+96.32%
3 months-77.78%
Date Price Change
14/24/14 0.32 0.00%
13/24/13 0.32 -13.51%
12/24/12 0.37 0.00%
11/24/11 0.37 -9.76%
10/24/10 0.41 -10.87%

Delayed Quote Deutsche Boerse AG

Last update June 14, 2024 at 11:35 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM9PP7
ISINDE000VM9PP76
Date issued 02/02/2024
Strike 380 $
Maturity 20/09/2024 (97 Days)
Parity 10 : 1
Emission price 1.14
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.72
Lowest since issue 0.163
Spread 0.03
Spread %7.32%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
345 USD
Average target price
372.5 USD
Spread / Average Target
+7.98%
Consensus